Articles with public access mandates - David SheridanLearn more
Not available anywhere: 2
Omega‐3 fatty acids and/or fluvastatin in hepatitis C prior non‐responders to combination antiviral therapy–a pilot randomised clinical trial
DA Sheridan, SH Bridge, MME Crossey, DJ Felmlee, FI Fenwick, ...
Liver International 34 (5), 737-747, 2014
Mandates: UK Medical Research Council, National Institute for Health Research, UK
Depressive symptoms in chronic hepatitis C are associated with plasma apolipoprotein E deficiency
DA Sheridan, SH Bridge, MME Crossey, DJ Felmlee, HC Thomas, ...
Metabolic brain disease 29, 625-634, 2014
Mandates: UK Medical Research Council, National Institute for Health Research, UK
Available somewhere: 26
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
ZM Younossi, V Ratziu, R Loomba, M Rinella, QM Anstee, Z Goodman, ...
The Lancet 394 (10215), 2184-2196, 2019
Mandates: National Institute for Health Research, UK
Accuracy of FibroScan controlled attenuation parameter and liver stiffness measurement in assessing steatosis and fibrosis in patients with nonalcoholic fatty liver disease
PJ Eddowes, M Sasso, M Allison, E Tsochatzis, QM Anstee, D Sheridan, ...
Gastroenterology 156 (6), 1717-1730, 2019
Mandates: National Institute for Health Research, UK
FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation …
PN Newsome, M Sasso, JJ Deeks, A Paredes, J Boursier, WK Chan, ...
The lancet Gastroenterology & hepatology 5 (4), 362-373, 2020
Mandates: National Institute for Health Research, UK
Assessment of hepatic steatosis by controlled attenuation parameter using the M and XL probes: an individual patient data meta-analysis
D Petroff, V Blank, PN Newsome, CS Voican, M Thiele, V de Lédinghen, ...
The Lancet Gastroenterology & Hepatology 6 (3), 185-198, 2021
Mandates: National Institute for Health Research, UK, European Commission, Federal …
Interferon-λ rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease
M Eslam, AM Hashem, R Leung, M Romero-Gomez, T Berg, GJ Dore, ...
Nature communications 6 (1), 6422, 2015
Mandates: National Health and Medical Research Council, Australia
Seladelpar (MBX-8025), a selective PPAR-δ agonist, in patients with primary biliary cholangitis with an inadequate response to ursodeoxycholic acid: a double-blind, randomised …
D Jones, PF Boudes, MG Swain, CL Bowlus, MR Galambos, BR Bacon, ...
The lancet Gastroenterology & hepatology 2 (10), 716-726, 2017
Mandates: UK Medical Research Council, National Institute for Health Research, UK
MBOAT7 rs641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis C
K Thabet, A Asimakopoulos, M Shojaei, M Romero-Gomez, A Mangia, ...
Nature communications 7 (1), 12757, 2016
Mandates: National Health and Medical Research Council, Australia, German Research …
Diverse impacts of the rs58542926 E167K variant in TM6SF2 on viral and metabolic liver disease phenotypes
M Eslam, A Mangia, T Berg, HLY Chan, WL Irving, GJ Dore, ML Abate, ...
Hepatology 64 (1), 34-46, 2016
Mandates: National Health and Medical Research Council, Australia, UK Medical Research …
IFN-λ3, not IFN-λ4, likely mediates IFNL3–IFNL4 haplotype–dependent hepatic inflammation and fibrosis
M Eslam, D McLeod, KS Kelaeng, A Mangia, T Berg, K Thabet, WL Irving, ...
Nature Genetics 49 (5), 795-800, 2017
Mandates: National Health and Medical Research Council, Australia, UK Medical Research …
FibroGENE: A gene-based model for staging liver fibrosis
M Eslam, AM Hashem, M Romero-Gomez, T Berg, GJ Dore, A Mangia, ...
Journal of hepatology 64 (2), 390-398, 2016
Mandates: National Health and Medical Research Council, Australia, UK Medical Research …
IFNL3 polymorphisms predict response to therapy in chronic hepatitis C genotype 2/3 infection
M Eslam, R Leung, M Romero-Gomez, A Mangia, WL Irving, D Sheridan, ...
Journal of hepatology 61 (2), 235-241, 2014
Mandates: National Health and Medical Research Council, Australia, National Institute …
Randomised clinical trial: palliative long‐term abdominal drains vs large‐volume paracentesis in refractory ascites due to cirrhosis
L Macken, S Bremner, H Gage, M Touray, P Williams, D Crook, L Mason, ...
Alimentary pharmacology & therapeutics 52 (1), 107-122, 2020
Mandates: Dunhill Medical Trust, UK, National Institute for Health Research, UK
A phase II, randomized, open-label, 52-week study of seladelpar in patients with primary biliary cholangitis
CL Bowlus, MR Galambos, RJ Aspinall, GM Hirschfield, DEJ Jones, ...
Journal of hepatology 77 (2), 353-364, 2022
Mandates: UK Medical Research Council
PCSK9, apolipoprotein E and lipoviral particles in chronic hepatitis C genotype 3: evidence for genotype-specific regulation of lipoprotein metabolism
SH Bridge, DA Sheridan, DJ Felmlee, MME Crossey, FI Fenwick, ...
Journal of hepatology 62 (4), 763-770, 2015
Mandates: Canadian Institutes of Health Research, UK Medical Research Council …
Care standards for non-alcoholic fatty liver disease in the United Kingdom 2016: a cross-sectional survey
DA Sheridan, G Aithal, W Alazawi, M Allison, Q Anstee, J Cobbold, ...
Frontline gastroenterology 8 (4), 252-259, 2017
Mandates: UK Medical Research Council
A variant in the MICA gene is associated with liver fibrosis progression in chronic hepatitis C through TGF-β1 dependent mechanisms
RE Sharkawy, A Bayoumi, M Metwally, A Mangia, T Berg, ...
Scientific reports 9 (1), 1439, 2019
Mandates: National Health and Medical Research Council, Australia, German Research …
Infection with the hepatitis C virus causes viral genotype-specific differences in cholesterol metabolism and hepatic steatosis
DA Sheridan, IT Shawa, EL Thomas, DJ Felmlee, SH Bridge, D Neely, ...
Scientific Reports 12 (1), 5562, 2022
Mandates: UK Medical Research Council, National Institute for Health Research, UK …
TLL1 rs17047200 increases the risk of fibrosis progression in caucasian patients with chronic hepatitis C
M John, M Metwally, A Mangia, M Romero-Gomez, T Berg, D Sheridan, ...
Gastroenterology 153 (5), 1448-1449, 2017
Mandates: National Health and Medical Research Council, Australia
Publication and funding information is determined automatically by a computer program